Streptococcus thermophilus iHA318 Improves Dry Eye Symptoms by Mitigating Ocular Surface Damage in a Mouse Model
Microorganisms · 27.06.2024 · 12 (7) · 1306
DOI: 10.3390/microorganisms12071306 ↗Kurz gefasst
Fachartikel in der Zeitschrift Microorganisms, online erschienen am 27.06.2024. Verfasst von Yu-Wei Chang und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Laboratory and Biotechnology, Chung Shan Medical University, Taichung 40201, Taiwan. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Percheron Bioceutical Co. Ltd., Taichung, Taiwan, Percheron Bioceutical Co., Ltd., Taichung, Taiwan.
Abstract (Originalsprache)
Dry eye is a complicated ocular surface disease that causes discomfort, visual disturbance, and frequently observed ocular surface damage. Emerging hypotheses suggest probiotics may help relieve dry eye symptoms by modulating inflammation and oxidative stress. This study aimed to investigate the therapeutic effects of Streptococcus thermophilus iHA318 probiotics on dry eye using in vitro assays and an in vivo murine model of ultraviolet B (UVB) radiation-induced dry eye. In vitro analyses revealed that S. thermophilus iHA318® exhibited antioxidant activity and anti-inflammatory effects by inhibiting reactive oxygen species production and suppressing inflammatory cytokines. For the in vivo study, female ICR mice were assigned to normal control, UVB-induced dry eye, and UVB+iHA318 treatment groups. UVB exposure significantly decreased tear volume and tear film breakup time (TBUT) compared to normal controls. Supplementation with S. thermophilus iHA318® via oral gavage markedly improved tear production and TBUT on day 7 post-UVB exposure. Ocular surface photography demonstrated improved gradings of corneal opacity, smoothness, and lissamine green staining in the iHA318 group versus the UVB group. Topographical analysis further revealed improvement in the UVB-induced corneal irregularities by iHA318 treatment. Collectively, these results indicate that S. thermophilus iHA318 exerts a protective effect against dry eye symptoms by mitigating oxidative stress and inflammation, thereby preserving tear film stability and ocular surface integrity. This probiotic strain represents a promising therapeutic approach for managing dry eye syndrome.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Medical Laboratory and Biotechnology, Chung Shan Medical University, Taichung 40201, Taiwan.
- Institute of Medicine, Chung Shan Medical University, Taichung 40201, Taiwan.
- Percheron Bioceutical Co., Ltd., Taichung 40201, Taiwan.
- Department of Nutrition, Chung Shan Medical University, Taichung 40201, Taiwan.
- Department of Ophthalmology, Chung Shan Medical University Hospital, Taichung 40201, Taiwan.
ORCID-Profile: Yu-Wei Chang, Chin-Hsiu Yu, Han-Hsin Chang, David Pei-Cheng Lin
Förderung
- Percheron Bioceutical Co. Ltd., Taichung, Taiwan
- Percheron Bioceutical Co., Ltd., Taichung, Taiwan
Zitieren
APA
Chang, Y. W., Sun, Y. L., Chu, E., Hung, Y. Y., Liao, W. C., Tsai, S. M., Lu, T. H., Huang, P. C., Yu, C. H., Lee, S. Y., Chang, H. H., & Lin, D. P. (2024). Streptococcus thermophilus iHA318 Improves Dry Eye Symptoms by Mitigating Ocular Surface Damage in a Mouse Model. Microorganisms, 12(7), 1306. https://doi.org/10.3390/microorganisms12071306
Vancouver
Chang YW, Sun YL, Chu E, Hung YY, Liao WC, Tsai SM, et al. Streptococcus thermophilus iHA318 Improves Dry Eye Symptoms by Mitigating Ocular Surface Damage in a Mouse Model. Microorganisms. 2024;12(7):1306. doi:10.3390/microorganisms12071306
BibTeX
@article{Chang2024,
author = {Chang, Yu-Wei and Sun, Yen-Ling and Chu, Evelyn and Hung, Yi-Yun and Liao, Wei-Chieh and Tsai, Su-Min and Lu, Tsung-Han and Huang, Pin-Chao and Yu, Chin-Hsiu and Lee, Shao-Yu and Chang, Han-Hsin and Lin, David Pei-Cheng},
title = {Streptococcus thermophilus iHA318 Improves Dry Eye Symptoms by Mitigating Ocular Surface Damage in a Mouse Model},
journal = {Microorganisms},
year = {2024},
volume = {12},
number = {7},
pages = {1306},
doi = {10.3390/microorganisms12071306}
}
EUVIMED